TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCI) on Tuesday reported a loss of $5.8 million in its third quarter.
On a per-share basis, the Toronto-based company said it had a loss of $1.85.
The drug developer posted revenue of $1.9 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CSCI at https://www.zacks.com/ap/CSCI
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
